Form D · Biotechnology
Noxilizer Inc
Baltimore, MD · CIK 0001407075
Offering snapshot reported Oct 22, 2010 · SEC filing
- Reported sold
- $3.59M Offering amount: $3.59M
- Investors reported
- 48 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 27, 2008 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 22, 2010 | Initial | $3,590,105 | No comparison | 48 | SEC filing |
| Oct 22, 2010 | Initial | $1,936,112 | No comparison | 37 | SEC filing |
| Oct 22, 2010 | Initial | $145,000 | No comparison | 5 | SEC filing |
| Oct 22, 2010 | Initial | $775,000 | No comparison | 8 | SEC filing |
| Jan 5, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 16, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-149489
Source: Form D, filed Oct 22, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John L. Brooks | Director |
| Lawrence Bruder | Director, Executive |
| Lars Hanan | Director |
| Kyle Salyers | Director |
| Edward Samulski | Director |
| Stephen Schaefer | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1450 South Rolling Road
Baltimore, MD, 21227
Baltimore, MD, 21227